Melanotan-2

A peptide studied in melanocortin signaling

Melanotan-2

Melanotan-II (MT-II) — Research-Based Peptide Benefits & Scientific Profile

Melanotan-II (MT-II) is a synthetic cyclic heptapeptide analog of alpha-melanocytestimulating hormone (α-MSH) that has been widely used in controlled laboratory and clinical research to study melanocortin receptor biology and its effects on pigmentation, sexual function, appetite regulation, and energy homeostasis. MT-II’s structure and receptor interactions make it valuable in preclinical investigations into melanogenesis and central nervous system pathways.

Scientific & Chemical Identification

  • CAS Number: 121062-08-6
  • Molecular Formula: C₅₀H₆₉N₁₅O₉
  • Molecular Weight (M.W.): ~1024.18 g/mol
  • Amino Acid Sequence: Ac-Nle-cyclo[Asp-His-D-Phe-Arg-Trp-Lys]-NH₂
  • Synonyms: Melanotan II, MT-II

Peptide Mechanism & Receptor Activity
Melanotan-II acts as a non-selective agonist at melanocortin receptors (MC1R, MC3R, MC4R, and MC5R), mimicking certain effects of endogenous α-MSH in research models. Its cyclic structure, including a lactam bridge, increases stability and affinity compared to natural peptides.

Research-Documented Effects & Benefits

  • Enhanced Melanogenesis & Tanning: MT-II activates MC1R in melanocytes, increasing melanin production and resulting in deeper skin pigmentation in experimental settings, with or without UV exposure.
  • Sexual Function Activation: Pilot Phase I clinical research showed that subcutaneous MT-II administration can trigger spontaneous erections and sexual arousal responses in normal male volunteers, correlating with central MC4R activation.
  • Appetite & Energy Regulation: Agonism of MC3R and MC4R has been explored for appetite suppression and modulation of energy balance in laboratory models.
  • Neuroprotective & CNS Pathways: Some preclinical studies suggest that MT-II may engage central melanocortin circuits, affecting cognitive function and mood, although the evidence is early and primarily experimental.

Key Research Studies

  • A pilot Phase I clinical trial in healthy male subjects demonstrated MT-II’s superpotent melanotropic activity, with documented autonomic effects, including somnolence, nausea, and spontaneous erections, following controlled dosing.
  • Research on melanocortin signal transduction has contributed to a broader understanding of MC receptor activation in pigmentation and sexual arousal mechanisms.
Syringe size
Amount in vial
Selected amount (mg)
10 mg
Water to mix
Total water (mL)
3 mL
Dosage per unit
Peptide per 0.01 mL
33 mcg per unit (0.01 mL)
Recommended dose
Suggested starting dose
250 mcg
Units to draw
Based on selected syringe size
8 units
Visual results
Draw — units

250 mcg

100 mcg

60-90 Days

Daily

Subcutaneous

Anytime